Night-time sedating H1 antihistamine increases daytime somnolence but not treatment efficacy in chronic spontaneous urticaria: a randomized controlled study

被引：2
|
作者：
Grattan, C. [1 ]
机构：
[1] Norfolk & Norwich Univ Hosp, Dermatol Ctr, Colney NR4 7UY, England
来源：
BRITISH JOURNAL OF DERMATOLOGY | 2014年 / 171卷 / 01期
关键词：
D O I：
10.1111/bjd.13112
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：8 / 9
页数：3
相关论文
共 50 条
  • [21] Positive Pressure Ventilation Treatment Based on Daytime and Night-time Titration in Patients with Obesity Hypoventilation Syndrome: A Randomized Controlled Trial
    Amra, Babak
    Ghasemi, Marzieh
    Soltaninejad, Forogh
    Salmasi, Mehrzad
    SLEEP SCIENCE, 2023, 16 (03) : E278 - E283
  • [22] Efficacy and Safety of Omalizumab in Patients with Chronic Idiopathic/Spontaneous Urticaria who Remain Symptomatic on H1 Antihistamines: A Randomized, Placebo-Controlled Study (vol 135, pg 67, 2015)
    Saini, Sarbjit S.
    Bindslev-Jensen, Carsten
    Maurer, Marcus
    Grob, Jean-Jacques
    Baskan, Emel Buelbuel
    Bradley, Mary S.
    Canvin, Janice
    Rahmaoui, Abdelkader
    Georgiou, Panayiotis
    Alpan, Oral
    Spector, Sheldon
    Rosen, Karin
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2015, 135 (03) : 925 - 925
  • [23] Effect of omalizumab on angioedema in H1-antihistamine-resistant chronic spontaneous urticaria patients: results from X-ACT, a randomized controlled trial
    Staubach, P.
    Metz, M.
    Chapman-Rothe, N.
    Sieder, C.
    Braeutigam, M.
    Canvin, J.
    Maurer, M.
    ALLERGY, 2016, 71 (08) : 1135 - 1144
  • [24] The Added-on of Ziziphus jujube Syrup in the Treatment of Chronic Spontaneous Urticaria Resistant to Standard-Dose of Secondary- generation H1 Antihistamine: A Double-Blind Randomized Clinical Trial
    Zare, Hamid
    Nabavizdeh, Seyed Hesamedin
    Jaladat, Amir Mohamad
    Zarshenas, Mohamad Mehdi
    Moghtaderi, Mozhgan
    Basirat, Atefeh
    Nasri, Nahid
    IRANIAN JOURNAL OF MEDICAL SCIENCES, 2023, 48 (06) : 582 - 590
  • [25] Efficacy evaluation of acupuncture combined with pricking blood therapy in the treatment of chronic spontaneous urticaria: a randomized controlled trial
    Du, Yuzhu
    Xue, Yuqiang
    Liu, Xiang
    Shi, Yu
    Sun, Mingxin
    Liu, Wenshan
    Li, Hongkun
    Sun, Bin
    Pan, Shijie
    Wang, Yanjun
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2024, 16 (10): : 5268 - 5282
  • [26] Efficacy and safety of switching to bilastine, an H1-antihistamine, in patients with refractory chronic spontaneous urticaria (H1-SWITCH): a multicenter, open-label, randomized, parallel-group comparative study
    Fukunaga, Atsushi
    Kakei, Yasumasa
    Murakami, Sae
    Kan, Yuji
    Masuda, Koji
    Jinnin, Masatoshi
    Washio, Ken
    Amano, Hiroo
    Nagano, Tohru
    Yamamoto, Akihisa
    Otsuka, Toshihiro
    Takahagi, Shunsuke
    Takenaka, Motoi
    Ishiguro, Naoko
    Hayama, Koremasa
    Inomata, Naoko
    Nakagawa, Yukinobu
    Sugiyama, Akiko
    Hide, Michihiro
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [27] Omalizumab in patients with chronic spontaneous urticaria nonresponsive to H1-antihistamine treatment: results of the phase IV open-label SUNRISE study
    Berard, F.
    Le Bouedec, M. C. Ferrier
    Bouillet, L.
    Reguiai, Z.
    Barbaud, A.
    Cambazard, F.
    Milpied, B.
    Pelvet, B.
    Kasujee, I.
    Gharbi, H.
    Lacour, J. P.
    BRITISH JOURNAL OF DERMATOLOGY, 2019, 180 (01) : 56 - 66
  • [28] Dupilumab Improves Dermatology-Specific Quality of Life in Patients with Chronic Spontaneous Urticaria Inadequately Controlled with H1 Antihistamines
    Maurer, Marcus
    Casale, Thomas B.
    Beck, Lisa A.
    Saini, Sarbjit
    Ben-Shoshan, Moshe
    Yosipovitch, Gil
    Msihid, Jerome
    Sugerman, Philip
    Cyr, Sonya
    Thomas, Ryan
    Chuang, Chien-Chia
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2024, 153 (02) : AB3 - AB3
  • [29] Angioedema and Angioedema Management From Asteria I and Asteria II: Phase III Studies To Evaluate The Efficacy and Safety Of Omalizumab In Patients With Chronic Idiopathic/Spontaneous Urticaria Who Remain Symptomatic Despite H1 Antihistamine Treatment
    Zazzali, James
    Rosen, Karin
    Bradley, Mary S.
    Raimundo, Karina
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2014, 133 (02) : AB117 - AB117
  • [30] Angioedema and angioedema management from ASTERIA II: a phase III, randomised, double-blind, placebo-controlled study to evaluate the efficacy and safety of omalizumab in patients with chronic idiopathic/spontaneous urticaria (CIU/CSU) who remain symptomatic despite H1 antihistamine treatment
    Zazzali, J. L.
    Rosen, K. E.
    Hsieh, H-J
    ALLERGY, 2013, 68 : 43 - 43
12345